Inflammation and immune suppression fuel aggressive SCLC behavior and spread
Unlocking the Secrets of Aggressive Lung Cancer: A New Path to Treatment? Small cell lung cancer (SCLC) remains a formidable foe, with a dismal five-year survival rate hovering around just five percent. While initially responsive to chemotherapy, the cancer’s tendency to rapidly relapse has fueled a critical search for the underlying biological mechanisms driving its … Read more